Countries citing papers authored by H. M. Vriesendorp
Since
Specialization
Citations
This map shows the geographic impact of H. M. Vriesendorp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. M. Vriesendorp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. M. Vriesendorp more than expected).
Fields of papers citing papers by H. M. Vriesendorp
This network shows the impact of papers produced by H. M. Vriesendorp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. M. Vriesendorp. The network helps show where H. M. Vriesendorp may publish in the future.
Co-authorship network of co-authors of H. M. Vriesendorp
This figure shows the co-authorship network connecting the top 25 collaborators of H. M. Vriesendorp.
A scholar is included among the top collaborators of H. M. Vriesendorp based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with H. M. Vriesendorp. H. M. Vriesendorp is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
All Works
20 of 20 papers shown
1.
Lai, Jing, et al.. (1999). Pharmacokinetics of radiolabeled polyclonal antiferritin in patients with Hodgkin's disease.. PubMed. 5(10 Suppl). 3315s–3323s.7 indexed citations
2.
Vriesendorp, H. M., et al.. (1999). Fractionated radiolabeled antiferritin therapy for patients with recurrent Hodgkin's disease.. PubMed. 5(10 Suppl). 3324s–3329s.24 indexed citations
3.
Vriesendorp, H. M., Hee Ho Chu, Timothy G. Ochran, Pablo Besa, & Richard E. Champlin. (1995). Total body irradiation and the therapeutic ratio of bone marrow transplantation. Bone Marrow Transplantation. 15(1).1 indexed citations
Vigneulle, R. M., et al.. (1989). Survival after total-body irradiation. I. Effects of partial small bowel shielding.. PubMed. 119(2). 313–24.9 indexed citations
Vriesendorp, H. M.. (1985). Optimal prescription method for cancer chemotherapy.. PubMed. 13 Suppl 16. 57–63.10 indexed citations
13.
Gordon, Leo I., et al.. (1984). Estimation of hemopoietic potential by CFU-c and bone marrow scan in cancer patients.. PubMed. 12(2). 101–6.1 indexed citations
Vriesendorp, H. M., et al.. (1976). Influence of genetic resistance and silica particles on survival after bone marrow transplantation.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 8(3). 483–9.12 indexed citations
18.
Bull, Robert W., H. M. Vriesendorp, A Zweibaum, & Scott N. Swisher. (1975). The inapplicability of CEA-7 as a canine bone marrow transplantation marker.. PubMed. 7(4). 575–7.5 indexed citations
19.
Tweel, Jan G. van den, H. M. Vriesendorp, A. Termijtelen, et al.. (1974). GENETIC ASPECTS OF CANINE MIXED LEUKOCYTE CULTURES. The Journal of Experimental Medicine. 140(3). 825–836.12 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.